NCT06390163

Brief Summary

The goal of this single blind randomized controlled trial is to investigate the effect of sensory-motor integration training on cognitive functions, balance and gait in patients with Parkinson Disease? The main questions it aims to answer are:

  • Does sensory-motor integration training have an effect on balance in patients with Parkinson Disease?
  • Does sensory-motor integration training have an effect on cognitive functions in patients with Parkinson Disease?
  • Does sensory-motor integration training have an effect on gait in patients with Parkinson Disease? Patients in the control group will be asked to continue their routine lives and return for evaluation after 8 weeks. Individuals in the control group will be followed without any additional treatment or advice. Patients in the study group will receivesensory-motor integration training for 60 minutes, 3 days a week for 8 weeks, in addition to their routine lives. No additional recommendations will be given to individuals in either group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 30, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

May 5, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2024

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

March 1, 2024

Last Update Submit

December 21, 2024

Conditions

Keywords

BalanceGaitCognitive FunctionSensory-perception-motor training

Outcome Measures

Primary Outcomes (8)

  • Static Posturography

    It measures postural stability while standing statically and dynamically. The device has a computer-connected force platform that measures the vertical forces applied on the patients\' feet (center of pressure/COG) to measure the position of the center of gravity and postural control.

    Baseline, week 8 and week 12

  • Modified Dynamic Gait Index

    Index is used to evaluate and document the ability to respond to changing task demands during gait. An increase in the score indicates that the patient\'s walking ability is better.

    Baseline, week 8 and week 12

  • Functional Reach Test

    It is used to evaluate dynamic balance and anteroposterior stability. In the standing position, the arm is lifted 90° upwards and stretched forward as much as possible, without losing contact with the feet. Initially, the projection of the acromion and the 3rd metacarpal bone on the wall is marked. At the final point reached after reaching forward, the projection of the 3rd metacarpal bone on the wall is marked and the difference is calculated. In elderly individuals, there is a risk of falling if the reach distance is less than 25.4 cm, and there is a risk of serious falling if it is less than 15 cm.

    Baseline, week 8 and week 12

  • Quick Mild Cognitive Impairment Screen

    It consists of 6 subtests: orientation, registration, clock drawing, delayed recall, verbal fluency and logical memory. This has a high degree of sensitivity in detecting cognitive impairment. It is also quick to apply, taking 3 to 5 minutes. There are cutoff points that are adjusted for factors such as age and education level. The total score is 100, and a score below 62 points indicates cognitive impairment.

    Baseline, week 8 and week 12

  • Symbol Digit Modalities Test

    It is a test frequently used in clinics because it evaluates attention, visuo-spatial information processing speed and working memory. Test is based on matching meaningless geometric shapes with certain numbers. The first 10 symbols are considered trials. Then the test starts and the person gets points for the correct marking he makes within 90 seconds. The maximum score is 60. Turkish Standardization of the test battery containing the relevant test was made and permission was obtained from the relevant authors

    Baseline, week 8 and week 12

  • Stroop Test

    The Stroop Test, which also measures the ability to change perceptual setup and response under disruptive influence, information processing speed and attention (especially selective attention).Increasing time and error indicates lower cognitive level.

    Baseline, week 8 and week 12

  • Clock Drawing Test

    Clock drawing test is an easy, quickly applicable, paper-and-pencil test with high validity and reliability used to evaluate visual-motor functions, planning, sequencing and abstract thinking skills. The Shulmann method will be used for scoring and this method evaluates out of a total of 5 points. An increase in the score indicates a better cognitive level.

    Baseline, week 8 and week 12

  • Movement Disorders Society Unified Parkinson's Disease Rating Scale - Part 3

    It is the revised form developed in 1980, by the Movement Disorders Association in 2008. It is a revised version that will eliminate the uncertainties present in scale and include current scientific developments. The number of questions, which was 42 in scale, was increased to 50 , and questions with yes/no options were removed because they caused structural inconsistency, and all questions were scored between 0 and 4. In our study, only the 3rd Part, which includes the Motor examination, will be used.

    Baseline, week 8 and week 12

Study Arms (2)

Sensory-motor Integration Training

EXPERIMENTAL

Patients in the study group will receive sensory-motor integration training for 60 minutes, 3 days a week for 8 weeks, in addition to their routine lives.

Other: Sensory-Motor Integration Training

Standart Care

NO INTERVENTION

Patients in the control group will be asked to continue their routine lives and return for evaluation after 8 weeks. Individuals in the control group will be followed without any additional treatment or advice.

Interventions

An exercise chain consisting of motor tasks, sensory stimuli and cognitive tasks will be created. Each session will include at least 3 motor tasks, 3 sensory stimuli and 3 cognitive tasks selected according to the patient's condition.

Sensory-motor Integration Training

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being diagnosed with idiopathic Parkinson's disease
  • Being between the ages of 45-75
  • Being between stage 2-3 according to the Modified Hoehn-Yahr Staging Scale
  • Having a score \> 21 on the Montreal Cognitive Assessment Scale
  • Being literate in Turkish
  • No drug or dose changes throughout the study.
  • Not having participated in any physiotherapy or rehabilitation program in the last 6 months.
  • Volunteering to participate in the study

You may not qualify if:

  • Presence of other neurological diseases
  • Presence of vision problems (that cannot be compensated with the correct lens) or vestibular disorders that may affect balance, other than symptoms related to Parkinson's disease.
  • Serious comorbidities that affect balance and gait or cannot be controlled with life-threatening medication (Diabetes, Hypertension, Cardiopulmonary diseases)
  • Long-term corticosteroid use
  • Presence of orthopedic and systemic diseases that may affect participation in exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Turkey (Türkiye)

Location

Related Publications (2)

  • Gandolfi M, Munari D, Geroin C, Gajofatto A, Benedetti MD, Midiri A, Carla F, Picelli A, Waldner A, Smania N. Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial. Mult Scler. 2015 Oct;21(11):1453-62. doi: 10.1177/1352458514562438. Epub 2015 Jan 12.

    PMID: 25583852BACKGROUND
  • Taghizadeh G, Azad A, Kashefi S, Fallah S, Daneshjoo F. The effect of sensory-motor training on hand and upper extremity sensory and motor function in patients with idiopathic Parkinson disease. J Hand Ther. 2018 Oct-Dec;31(4):486-493. doi: 10.1016/j.jht.2017.08.001. Epub 2017 Nov 14.

    PMID: 29150384BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Ayla Fil Balkan, Assoc.Prof

    Hacettepe University

    STUDY DIRECTOR
  • Süleyman Korkusuz, PhD

    Atılım University

    STUDY CHAIR
  • Ayşenur Özcan, MSc

    Çankırı Karatekin University

    STUDY CHAIR
  • Gül Yalçın Çakmaklı, Assoc.Prof.

    Hacettepe University

    STUDY CHAIR
  • Öznur Yiğit, Assisst.Prof

    Hacettepe University

    STUDY CHAIR
  • Bülent Elibol, Prof.Dr.

    Hacettepe University

    STUDY CHAIR
  • Büşra Seçkinoğulları Korkusuz, MSc

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 1, 2024

First Posted

April 30, 2024

Study Start

May 5, 2024

Primary Completion

October 20, 2024

Study Completion

October 30, 2024

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations